Kings College London will establish an Advanced Therapies Centre, bringing together expertise, manufacturing capability and experimental medicine research facilities for cell and gene therapy.
These therapies offer enormous promise for severe, intractable diseases, but their development is limited by access to clinical-grade manufacturing infrastructure and early-phase trials capabilities.
The Centre will be open to academic and industry partners across London and the UK, and support the planned Cell and Gene Therapy Catapult large-scale manufacturing facility.
The Centre will create a unique addition to the UK’s biomedical research and development capability. It will trigger a substantial investment in the UK by pharmaceutical companies, creating high value jobs, scientific advances, and ground-breaking improvements in healthcare.